Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

Market Cap	11.01B
Revenue (ttm)	4.05B
Net Income (ttm)	704.05M
Shares Out	825.93M
EPS (ttm)	0.83
PE Ratio	16.05
Forward PE	13.46
Dividend	0.35 (2.63%)
Ex-Dividend Date	May 24, 2024

Volume	11,077,700
Average Volume	9,796,623
Open	13.23
Previous Close	13.33
Day's Range	13.23 - 13.65
52-Week Range	9.88 - 14.78
Beta	0.10
RSI	52.12
Earnings Date	Aug 15, 2025

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 3,869
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002020

Financial Performance

In 2024, SHE:002020's revenue was 4.16 billion, an increase of 3.99% compared to the previous year's 4.00 billion. Earnings were 711.96 million, an increase of 15.04%.